Researcher

Fang Li

Sichuan Cancer Hospital

2 developments in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

Latest

Everything in the corpus, newest first.

SEP 4, 2026 · JOURNAL ARTICLE

A scoping review of non-pharmacological symptom management in head and neck cancer patients during the peri-chemoradiotherapy period

BMC Complementary Medicine and Therapies

A scoping review mapping the landscape of non-pharmacological interventions without quality assessment, effect synthesis, or meta-analysis; descriptive and gap-identifying rather than outcome-determining.

PreliminaryCancer Survivorship and Care Fang Li Aiping Wang

Reported

Number of eligible studies includ…68

Number of intervention categories9

Number of outcome measure categor…6

AUG 1, 2026 · JOURNAL ARTICLE

GABAB1R: A molecular bridge linking deep brain stimulation to antidepressant effects——A commentary on “NAcLat-DBS reduces GABAB1R expression of dopamine neurons to correct depressive symptoms in CMS mice"

Neurotherapeutics

This is a commentary piece proposing a molecular mechanism (GABAB1R expression in dopamine neurons) linking DBS to antidepressant effects, without original clinical or experimental data of its own.

Hypothesis-GeneratingFang Li Jing Sun Ming‐Hu Han

Reported

Treatment resistance rateapproximately one-third